<DOC>
	<DOCNO>NCT00372229</DOCNO>
	<brief_summary>This 2 arm study compare efficacy 100 day Valcyte ( 900mg po daily ) prophylaxis prophylaxis , condition pre-emptive therapy active CMV infection , CMV positive renal transplant recipient . The influence two prevention concept occurrence direct indirect effect active CMV infection compare . The anticipated time study treatment 3 months-1 year , target sample size 100-500 individual .</brief_summary>
	<brief_title>A Study Valcyte ( Valganciclovir ) CMV Prophylaxis After Renal Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Cytomegalovirus Infections</mesh_term>
	<mesh_term>Valganciclovir</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<criteria>primary secondary renal allograft within precede 14 day ; IgG seropositive CMV ; receive immunosuppressive therapy . active CMV infection ; current/history malignancy ; acute steroid resistant rejection episode since transplantation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>